title: Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2).
abstract: Matrix Gla protein (MGP) is an inhibitor of calcification of the arterial wall but the mechanism of inhibition has not been resolved. Since chondrogenesis has been identified in calcified arteries from MPG null mice, we hypothesized that locally produced MGP might inhibit calcification by neutralizing the known effect of bone morphogenetic proteins (BMPs) as promotors of chondrogenesis and bone formation. As the first step to test this hypothesis, we demonstrate that MGP is a binding protein for 125I-BMP-2. Optimal binding is dependent on metals which suggests that the metal binding Gla region in MGP is involved. MGP is shown to undergo a Ca++ induced conformational change despite the presence of the gamma-carboxylase binding site being part of the mature protein sequence. The data propose that MGP matures earlier in the secretory pathway than other vitamin K-dependent proteins. Antibodies were used in an attempt to identify MGP in bovine serum. Conformational specific MGP antibodies were shown to also recognize the Gla region in prothrombin and factor X but did not identify MGP in serum. This finding is supported by electrophoresis data which demonstrate the absence of MGP among Ba-citrate absorbed vitamin K-dependent serum proteins. We conclude that MGP does not exist in normal bovine serum.
authors.affiliation: Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1058, USA. rwallin@wfubmc.edu
authors.forename: R
authors.initials: R
authors.lastname: Wallin
authors.forename: D
authors.initials: D
authors.lastname: Cain
authors.forename: S M
authors.initials: SM
authors.lastname: Hutson
authors.forename: D C
authors.initials: DC
authors.lastname: Sane
authors.forename: R
authors.initials: R
authors.lastname: Loeser
mesh_terms: D000818:Animals; D000906:Antibodies / Q000378:metabolism; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002135:Calcium-Binding Proteins / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D002417:Cattle; D017124:Conserved Sequence; D000939:Epitopes / Q000378:metabolism; D016326:Extracellular Matrix Proteins; D005170:Factor X / Q000276:immunology; D006801:Humans; D010949:Plasma / Q000737:chemistry; D011485:Protein Binding / Q000187:drug effects; D017433:Protein Structure, Secondary / Q000187:drug effects; D011516:Prothrombin / Q000276:immunology; D016212:Transforming Growth Factor beta; D000097568:Matrix Gla Protein
chemical_list: D000906:Antibodies; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D002118:Calcium; D002135:Calcium-Binding Proteins; D000939:Epitopes; D016326:Extracellular Matrix Proteins; D005170:Factor X; D011516:Prothrombin; D016212:Transforming Growth Factor beta; D000097568:Matrix Gla Protein; C525718:BMP2 protein, human; C525719:Bmp2 protein, mouse